Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Rockwell Medical IN (RMTI)

Rockwell Medical IN (RMTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,319
  • Shares Outstanding, K 93,889
  • Annual Sales, $ 62,200 K
  • Annual Income, $ -30,890 K
  • 60-Month Beta 0.96
  • Price/Sales 0.96
  • Price/Cash Flow N/A
  • Price/Book 3.29
Trade RMTI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.36
  • Most Recent Earnings N/A on 08/16/21
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 410.73%
  • Historical Volatility 39.02%
  • IV Percentile 90%
  • IV Rank 36.80%
  • IV High 1,003.84% on 08/10/21
  • IV Low 65.41% on 06/15/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 36
  • Volume Avg (30-Day) 75
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 3,536
  • Open Int (30-Day) 2,694

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5923 +6.37%
on 09/20/21
0.6900 -8.70%
on 09/01/21
-0.0350 (-5.26%)
since 08/27/21
3-Month
0.5590 +12.70%
on 08/20/21
0.9800 -35.71%
on 06/28/21
-0.2821 (-30.93%)
since 06/25/21
52-Week
0.5590 +12.70%
on 08/20/21
1.9800 -68.18%
on 02/09/21
-0.4400 (-41.12%)
since 09/25/20

Most Recent Stories

More News
Rockwell Medical, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.6421 (-1.68%)
Rockwell Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes...

RMTI : 0.6421 (-1.68%)
Rockwell Medical (RMTI) Reports Q2 Loss, Misses Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -12.50% and -11.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

RMTI : 0.6421 (-1.68%)
Rockwell Medical: Q2 Earnings Snapshot

WIXOM, Mich. (AP) _ Rockwell Medical Inc. (RMTI) on Monday reported a loss of $8.4 million in its second quarter.

RMTI : 0.6421 (-1.68%)
Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RMTI : 0.6421 (-1.68%)
Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.6421 (-1.68%)
Rockwell Medical, Inc. Files Pre-IND Meeting Request with FDA for its Proposed Clinical Trial of FPC as a Treatment for Iron Deficiency Anemia in Patients Receiving Home Infusion

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.6421 (-1.68%)
Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.6421 (-1.68%)
Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic(R) in Turkey

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.6421 (-1.68%)
Rockwell Medical, Inc. to Present at the 2021 LD Micro Invitational XI

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world,...

RMTI : 0.6421 (-1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able...

See More

Key Turning Points

3rd Resistance Point 0.7204
2nd Resistance Point 0.6937
1st Resistance Point 0.6734
Last Price 0.6421
1st Support Level 0.6264
2nd Support Level 0.5997
3rd Support Level 0.5794

See More

52-Week High 1.9800
Fibonacci 61.8% 1.4372
Fibonacci 50% 1.2695
Fibonacci 38.2% 1.1018
Last Price 0.6421
52-Week Low 0.5590

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar